article thumbnail

Why veterans can’t discuss cannabis with VA doctors

The Cannigma

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. Veterans collectively discussed how the use of medical marijuana reduced PTSD symptoms, feelings of anxiety, and helped them sleep better.

article thumbnail

CA: DOJ Medical Cannabis

Cannabis Law Report

The summary also lets medicinal cannabis patients know both their rights and their responsibilities, he said.” There is no mention or discussion of Attorney General Brown’s 2008 Memorandum. The guidelines do not distinguish between “ collectives,” “cooperatives” and “ Chapter 22 cooperative associations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Research Shows Strong Support for Natural Therapeutics

Veriheal

Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. The survey’s findings have been frequently supported by doctors’ experiences with patients. Pioneering Psychedelic Research.

Therapy 98
article thumbnail

Cannabis for IBS: Treating Irritable Bowel Syndrome with Medical Marijuana

Greencamp

Irritable bowel syndrome (IBS) is a collection of symptoms which create discomfort in the abdominal area, resulting in the inflammation of the digestive tract. During a three-month period, 13 patients with long-standing IBS were given cannabis. Neuroendocrinology Letters; April 2008; 29(2):192-200. What is IBS?

article thumbnail

Jason Straw: Medical Cannabis Policy, ISNA 2020 Conference

Cannabis Law Report

The purpose of this statement is to reiterate the Indiana State Nurses Association’s ( IS NA) support for the review and reclassification of marijuana’s status from a federal Schedule I controlled substances to facilitate urgently needed clinical research to inform patients and providers on the efficacy of marijuana and related cannabinoids.

Policy 105
article thumbnail

Psyence Group Announces Appointment of New Chief Executive Officer

Cannabis Law Report

He has held various executive leadership positions, including heading up research and development and driving the scientific strategy at Bayer Pharmaceuticals as well as Wyeth Pharmaceuticals, where he was appointed interim President and general manager in 2008.

article thumbnail

GW suffers major blow as US sinks bid to patent cannabinoids for epilepsy

Cannabis Law Report

The invention covers a method of treating partial seizure comprising administering cannabidiol (CBD), to a patient wherein the CBD is present in an amount which provides a daily dose of at least 400 mg. Pure Hemp Collective Inc. (1:18-cv-01922), 1:18-cv-01922), is due before court later this year. “At